back
to list
ALLAN
BOWDITCH, EX-CEO OF GLOBAL HEALTHCARE FOR MARTIN HAMBLIN,
JOINS FORCES WITH THE ZIMENT GROUP
NEW YORK,
February 1, 2006 -
Allan Bowditch, a renowned and sought after healthcare
researcher responsible for building Martin Hamblin's
healthcare business over a 30 year period, has joined The
Ziment Group in a Strategic Advisor role.
"Having
known and competed with Allan for years I felt it was high
time to get him on our team" said Howard Ziment, Chief
Executive Officer of The Ziment Group. "He brings a depth of
knowledge of our industry that is unparalleled. We are
thrilled to bring someone with such a sterling reputation
for being one of the best global healthcare market
researchers in the history of our industry to our halls."
Bowditch
was CEO of Martin Hamblin until May of 2004. He was in an
advisory role to that company through mid-2005.
“The
Ziment Group is a dynamic, diverse organization", said
Bowditch. "The opportunity to bring the expertise I have
built throughout my career to such a place has limitless
possibilities."
In his
role as Strategic Advisor, Bowditch will assist The Ziment
Group in many ways, including the continued building of
Ziment's European efforts; in product development for all
group companies and in the training and development of
Ziment staff including moderators, analytic and project
staff. He will also continue his work in supporting the
healthcare and pharmaceutical marketing research industries
through his work with industry associations.
"Having someone with the
stature of Allan joining our organization will really help
build upon the terrific momentum we have in our primary
research business in Europe," said Andrew Scott, Managing
Director, Ziment Europe. "We look forward to a terrific year
in 2006."
In 2003 Bowditch was given a
Special Award for his contribution to Global Marketing
Research by EphMRA (European Pharmaceutical Market Research
Association) across his career. In 2005, he was given a
lifetime achievement award by PBIRG (Pharmaceutical Business
Intelligence Research Group),
an organization of US based
pharmaceutical companies who conduct global market research.
About The
Ziment Group:
The
Ziment Group consists of Ziment, a full service consultancy
offering custom marketing research for the healthcare and
pharmaceutical industries worldwide; WebSurveyResearch which
houses the largest dedicated panel of physicians with which
to conduct marketing research through the internet; imap
Research, a division dedicated to conducting syndicated
market tracking research; and Consumer Health Sciences,
which conducts the National Health and Wellness Survey (nhwsurvey.com),
the pre-eminent source of information about the flow of
patients into physicians' offices.
The
Ziment Group is the global healthcare research brand for The
Kantar Group, the Information and Consultancy Division of
WPP, plc. For more information on the group and its
divisions, go to
www.zimentgroup.com.
^ Top ^
|
